KREBS BIOCHEMICALS & INDUSTRIES
|
The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 5.31.
| Share Price | ₹66.9 | Nov 12,2025 |
| Market Cap | ₹144.5 Cr | |
| Sales-TTM | ₹27.2 Cr | TTM-Standalone Results |
| Price/Sales | 5.31x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹144.5 Cr] as on Nov 12,2025
(/) Sales [ ₹27.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.31x ]
Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '5.31 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES
PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.34x.
- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.
How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| KREBS BIOCHEMICALS & INDUSTRIES | 27.2 | 5.31 | 144.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.56 | 415,529.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.26 | 173,067.0 |
| CIPLA LTD | 28,349.6 | 4.33 | 122,773.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.56 | 129,376.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.99 | 102,595.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.91 | 93,824.1 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.91 | 95,713.0 |
| LUPIN LTD | 24,750.7 | 3.76 | 92,989.9 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.12 | 69,007.9 |
| ABBOTT INDIA LTD | 6,714.4 | 9.36 | 62,818.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.12x |
| Max industry PS | 17.26x |
| Median industry PS | 5.31x |
| Average industry PS | 6.73x |
You may also like the below Video Courses